Hopes of a coronavirus vaccine mount as three key biotech players make progress

CNBC March 17, 2020
Julianna Tatelbaum

Key Points

– Over the last 48 hours, three biotech companies, in particular, have been thrust into the spotlight for their promise: BioNTech, CureVac and Moderna.

– All three of these firms specialize in messenger RNA (mRNA) therapeutics.

– These mRNA molecules are used to instruct the body to produce its own immune response to fight a range of different diseases.

The race is on to develop an immunization against COVID-19.

Dozens of companies and public labs around the world are working to develop a vaccine to prevent the spread of the flu-like virus. Over the last 48 hours, three biotech companies, in particular, have been thrust into the spotlight for their promise: BioNTech, CureVac and Moderna.

All three...

Today's Sponsors

Today's Sponsor